中国组织工程研究 ›› 2015, Vol. 19 ›› Issue (27): 4288-4292.doi: 10.3969/j.issn.2095-4344.2015.27.005

• 骨髓干细胞 bone marrow stem cells • 上一篇    下一篇

心肌缺血再灌注损伤模型大鼠经艾塞那肽预处理后心肌细胞的凋亡

李文凯1,尚  斌1,连小鹏1,马  捷2   

  1. 1山西医科大学,山西省太原市  030001; 2山西医科大学第二医院心胸外科,山西省太原市  030001
  • 出版日期:2015-06-30 发布日期:2015-06-30
  • 通讯作者: 马捷,博士,教授,主任医师,博士生导师,山西医科大学第二医院心胸外科,山西省太原市 030001
  • 作者简介:李文凯,女,1989年生,山西省晋城市人,汉族,山西医科大学在读硕士。

Cardiomyocyte apoptosis in rats with myocardial ischemia/reperfusion injury after Exendin-4 pretreatment 

Li Wen-kai1, Shang Bin1, Lian Xiao-peng1, Ma Jie2   

  1. 1Shanxi Medical University, Taiyuan 030001, Shanxi Province, China; Department of Cardiothoracic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Online:2015-06-30 Published:2015-06-30
  • Contact: Ma Jie, M.D., Professor, Chief physician, Doctoral supervisor, Department of Cardiothoracic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • About author:Li Wen-kai, Studying for master’s degree, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China

摘要:

背景:有研究表明艾塞那肽可改善心肌梗死和心力衰竭等过程发挥心血管保护作用,但其对缺血再灌注损伤后心肌细胞凋亡的作用尚未阐明。
目的:艾塞那肽预处理心肌缺血再灌注损伤模型大鼠,观察其对心肌组织细胞凋亡及对凋亡因子Bcl-2、Bax表达的影响。
方法:建立心肌缺血再灌注损伤模型大鼠,用艾塞那肽进行预处理,并设缺血再灌注组和假手术组作对照。
结果与结论:免疫组织化学染色、原位末端标记检测RT-PCR检测显示,与缺血再灌注组比较,艾塞那肽组Bcl-2的mRNA和蛋白表达显著升高(P < 0.05),Bax mRNA和蛋白表达显著降低(P < 0.05),心肌细胞凋亡指数显著降低(P < 0.05)。结果证实,艾塞那肽对大鼠心肌缺血再灌注有保护作用,其机制可能是通过上调Bcl-2的表达,下调Bax的表达,从而抑制心肌细胞凋亡有关。

中国组织工程研究杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程

关键词: 实验动物, 心肺及血管损伤动物模型, 艾塞那肽, 心肌缺血再灌注, 细胞凋亡, Bax, Bcl-2, RT-PCR, 大鼠

Abstract:

BACKGROUND: Exendin can regulate blood glucose, blood lipid and blood pressure, exert anti-inflammation and anti-oxidative stress effects, improve myocardial infarction and heart failure, and protect heart vessels. However, the effect on the apoptosis of cardiac muscle cells after ischemia/reperfusion injury remains unclear.
OBJECTIVE: To observe the effects of Exendin-4 pretreatment on the cardiomyocyte apoptosis and the expression of Bcl-2 and Bax in rats with myocardial ischemia/reperfusion injury.
METHODS: The myocardial ischemia/reperfusion injury model was established in rats and then received Exendin-4 pretreatment. Ischemia/reperfusion group and sham operation group were set.
RESULTS AND CONCLUSION: Immunohistochemical staining, TUNEL and reverse transcriptase-polymerase chain reaction results showed that Bcl-2 protein and mRNA expression levels in the Exendin-4 group were significantly increased (P < 0.05), while Bax protein and mRNA expression levels were significantly decreased compared with ischemia/reperfusion group (P < 0.05). In addition, apoptosis index was more significantly decreased in the Exendin-4 group than in the ischemia/reperfusion group (P < 0.05). Exendin-4 can protect rat heart muscle against ischemia/reperfusion injury and effectively inhibit the apoptosis of cardiomyocytes, and the underlying mechanism is mediated by up-regulating Bcl-2 expression and down-regulating Bax expression.

中国组织工程研究杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程

Key words: Tissue Engineering, Myocardial Ischemia, Apoptosis, Genes 

中图分类号: